The adhesive/strap-free, comfortable design is ideal for elderly patients, preventing skin damage. Continual monitoring, including movement and falls, can prevent catastrophic outcomes.
Automation reduces demands on nursing staff, where nurses are already in short supply. Continuous flow of vitals data enables clinicians to gain a comprehensive view of patient health. EHR integration and other efficiencies drive cost savings.
The ability to continuously monitor and send data adds robustness to clinical trial data. Trials conducted in remote or resource-limited locations become more feasible and convenient for participants.
Automated monitoring ensures continuous data collection during intense activities, such as basic training and special forces screening. The durable, comfortable design and queuing capability ensure reliability in remote or high-contact environments and situations.
Real-time, uninterrupted monitoring supports mission-critical decision-making. Wireless communication and queuing prevent data loss in areas with limited connectivity, while the compact charging station enables easy field deployment.
Comfort and long-term wearability enhance adherence to treatment plans, while continuous vitals monitoring provides clinicians with valuable data for recovery tracking. Wireless recharging and integration with EHRs simplify ongoing care and improve outcomes.
“This would save 30–50% on medication pass time — it would make me love my job again.”

SleeveSense is designed to fit into the existing healthcare workflow, providing a better patient experience, higher levels of satisfaction for nurses, increasingly comprehensive insights for specialists, and cost-savings opportunities for healthcare systems. The above patient journey example is specific to cardiovascular, however the benefits of SleeveSense can be achieved throughout the healthcare ecosystem.
SleeveSense™ will be available upon FDA clearance, which is expected in early 2027.
Senphonix is a Delaware C-Corp., with offices in Minnesota and Arizona. For more information, contact us at info@senphonix.com or 612-913-0607; or follow us on LinkedIn. Copyright © 2026 Senphonix, Inc. - All Rights Reserved. Logos and trademarks are the property of their respective owners. All quotes herein are drawn from anonymous responses to two MarketWise Advising ("MarketWise") national studies, commissioned by Senphonix; some quotes were lightly edited for brevity.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.